Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma
Multiple myeloma is a type of cancer prevalent in many parts of the world. This condition affects the plasma cells in bone marrow and is common among male adults over 60.
Miralle Kaldass was born and raised in Egypt. She received her pharmacy degree from the Faculty of Pharmacy, Cairo University, and has 5 years of experience as a pharmacist. The most rewarding part of her job is providing patient care where a patient's health can improve and allow them to live a better life. Her areas of expertise include long-term care with nursing homes and hospices, specialty pharmacy, and TPN. In her free time, she enjoys going to the gym, shopping, and walking by the beach.
Multiple myeloma is a type of cancer prevalent in many parts of the world. This condition affects the plasma cells in bone marrow and is common among male adults over 60.